================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant
to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): December 30, 2005
---------------------
CirTran Corporation
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Nevada
--------------------------------------------------------------------------------
(State of Other Jurisdiction of Incorporation)
0-26059 68-0121636
--------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
4125 South 6000 West, West Valley City, Utah 84128
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
801-963-5112
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 1.01 Entry into a Material Definitive Agreement
Item 2.03 Creation of a Direct Financial Obligation
Item 3.02 Unregistered Sales of Equity Securities
Sale of Convertible Debenture
-----------------------------
On December 30, 2005, CirTran Corporation (the "Company") entered into
a securities purchase agreement (the "Purchase Agreement") with Cornell Capital
Partners, a Delaware limited partnership (the "Investor"), relating to the sale
by the Company of a 5% Secured Convertible Debenture, due July [30], 2008, in
the aggregate principal amount of $1,500,000 (the "Debenture").
The Company also paid a commitment fee of $120,000, and a structuring
fee of $10,000 to the Investor. As such, of the total purchase amount of
$1,500,000, the net proceeds to the Company were $1,370,000. The Company will
use these proceeds for general corporate and working capital purposes, in its
discretion.
The Debenture bears interest at a rate of 5%. The Investor is entitled
to convert, at its option, all or part of the principal amount owing under the
Debenture into shares of the Company's common stock at a conversion price equal
one hundred percent (100%) of the lowest closing bid price of the Common Stock
as listed on the OTC Bulletin Board, as quoted by Bloomberg L.P. for the twenty
(20) trading days immediately preceding the Conversion Date Except as otherwise
set forth in the Debenture, the Investor's right to convert principal amounts
owing under the Debenture into shares of the Company's common stock is limited
as follows:
(i) The Investor may convert up to $250,000 worth of the principal
amount plus accrued interest of the Debenture in any
consecutive 30-day period when the market price of the
Company's stock is $0.10 per share or less at the time of
conversion;
(ii) The Investor may convert up to $500,000 worth of the principal
amount plus accrued interest of the Debenture in any
consecutive 30-day period when the price of the Company's
stock is greater than $0.10 per share at the time of
conversion, provided, however, that the Holder may convert in
excess of the foregoing amounts if the Company and the Holder
mutually agree; and
(iii) Upon the occurrence of an event of default (as defined in the
Debenture), the Investor may, in its sole discretion,
accelerate full repayment of all debentures outstanding and
accrued interest thereon or may, notwithstanding any
limitations contained in the Debenture and/or the Purchase
Agreement, convert the Debentures and accrued interest thereon
into shares of the Company's common stock pursuant to the
Debenture.
Under the terms of the Debenture, except upon an event of default as
defined in the Debenture, the Investor may not convert the Debenture for a
number of shares of common stock in excess of that number of shares of common
stock which, upon giving effect to such conversion, would cause the aggregate
number of shares of Common Stock beneficially owned by the Investor and its
2
affiliates to exceed 4.99% of the outstanding shares of the common stock
following such conversion.
Pursuant to the Debenture, interest is to be paid at the time of
maturity or conversion. The Company may, in its option, pay accrued interest in
cash or in shares of its common stock. If paid in stock, the conversion price
shall be the closing bid price of the common stock on either (i) the date the
interest payment is due; or (ii) if the interest payment is not made when due,
the date on which the interest payment is made.
Also pursuant to the Debenture, the Company has the right to redeem, by
giving 3 days' written notice to the Investor, a portion or all of the Debenture
then outstanding by paying an amount equal to one hundred five percent (105%) of
the amount redeemed plus interest accrued thereon. In the event that the Company
redeems only a portion of the outstanding principal amount of the Debenture, the
Investor may convert all or any portion of the unpaid principal or interest of
the Debenture not being redeemed by the Company. Additionally, if after the
earlier to occur of (x) fifteen (15) months following the date of the purchase
of the Debenture or (y) twelve (12) months following the date on which the
initial registration statement is declared effective, all or any portion of the
Debenture remains outstanding, then the Company, at the request of the Investor,
shall redeem such amount outstanding at the rate of five hundred thousand
dollars ($500,000) per each 30-day period. Finally, upon the occurrence of an
event of default as defined in the Debenture, the Investor can convert all
outstanding principal and accrued interest under this Debenture irrespective of
any of the limitations set forth in the Debenture and/or the Purchase Agreement,
and in such event, all such principal and interest shall become immediately due
and payable.
In connection with the Purchase Agreement, the Company also agreed to
grant to the Investor warrants (the "Warrants") to purchase up to an additional
10,000,000 shares of the Company's common stock. The Warrants have an exercise
price of $0.09 per share, and expire three years from the date of issuance. The
Warrants also provide for cashless exercise if at the time of exercise there is
not an effective warrant or if an event of default has occurred.
Additionally, the Company and the Investor entered into an investor
registration rights agreement (the "Registration Rights Agreement"), pursuant to
which, the Company agreed to file, within 120 days of the closing of the
purchase of the Debenture, a registration statement to register the resale of
shares of the Company's common stock issuable to the Investor upon conversion of
the Debenture. The Company agreed to register the resale of up to 42,608,696
shares, consisting of 32,608,696 shares underlying the Debenture, and 10,000,000
shares underlying the Warrants. The Company agreed to keep such registration
statement effective until all of the shares issuable upon conversion of the
Debenture have been sold. In the event that the Company issues more than
32,608,696 shares of its common stock upon conversion of the Debenture, it will
file additional registration statements as necessary.
The Company and the Investor also entered into a security agreement
(the "Security Agreement"), pursuant to which the Company granted a second
position security interest in all of its property, including goods; inventory;
contract rights and general intangibles; documents, receipts, and chattel paper;
accounts and other receivables; products and proceeds; and any interest in any
3
subsidiary, joint venture, or other investment interest to secure the Company's
obligation under the Debenture and the related agreements.
The Company and the Investor also entered into an escrow agreement (the
"Escrow Agreement") relating to the holding and disbursement of payment of the
purchase price of the Debenture and cash payments made by the Company in payment
of the obligations owing under the Debenture. The Company and the Investor
appointed David Gonzalez as the Escrow Agent under the Escrow Agreement.
The Company had previously entered into financing transactions with
Cornell Capital Partners, LP ("Cornell"), In April 2003, the Company had entered
into an equity line of credit agreement with Cornell, pursuant to which the
Company drew a total of $2,150,000 on the equity line, and issued a total of
57,464,386 shares of common stock to Cornell. In May 2004, the Company entered
into a standby equity distribution agreement, but the agreement was terminated
before any funds were drawn or any shares were issued. Between June 2003 and
January 2005, Cornell loaned to the Company an aggregate of $5,595,000 pursuant
to promissory notes issued to Cornell. These notes were paid in full by May
2005.
In May 2005, the Company sold convertible debentures in the aggregate
amount of $3,750,000, to Highgate House Funds, Ltd., a Cayman Island exempted
company ("Highgate"). Highgate and Cornell have the same general partner,
Yorkville Advisors, but have different portfolio managers. Additionally, the
escrow agent appointed in connection with the purchase and sale of both the
Cornell debenture transaction and the Highgate debenture transaction is David
Gonzalez, an officer of Cornell .
As of the date of this Current Report, no amount of the Debenture had
been converted and no shares of the Company's common stock had been issued to
the Investor. The Company sold the Debenture without registration under the
Securities Act of 1933, as amended (the "1933 Act") in reliance on Section 4(2)
of the 1933 Act, and the rules and regulations promulgated thereunder. Upon
future conversions, if any, of the Debenture into shares of the Company's common
stock, the Company intends to issue the shares without registration under the
1933 Act in reliance on Section 4(2) of the 1933 Act, and the rules and
regulations promulgated thereunder. As noted above, the Company anticipates that
any resales by the Investor of the shares issued upon conversion of the
Debenture will be made pursuant to a registration statement to be filed by the
Company.
The Company does not anticipate that it will use any of the proceeds of
the sale of the Debenture to Cornell to repay the Debenture sold to Highgate.
Item 9.01. Financial Statements and Exhibits.
(a) Financial Statements. None.
--------------------
(b) Pro Forma Financial Information. Not Applicable.
-------------------------------
(c) Exhibits.
--------
4
99.1 Securities Purchase Agreement between CirTran
Corporation and Cornell Capital Partners, LP, dated
as of December 30, 2005.
99.2 Form of 5% Convertible Debenture, due July 30, 2008,
issued by CirTran Corporation.
99.3 Investor Registration Rights Agreement between
CirTran Corporation and Cornell Capital Partners, LP,
dated as of December 30, 2005.
99.4 Security Agreement between CirTran Corporation and
Cornell Capital Partners, LP, dated as of December
30, 2005.
99.5 Escrow Agreement between CirTran Corporation, Cornell
Capital Partners, LP, and David Gonzalez dated as of
December 30, 2005.
99.6 Form of Warrant issued to Cornell Capital Partners,
LP, dated as of December 30, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CirTran Corporation
Date: January 5, 2005 By: /s/ Iehab J. Hawatmeh
------------------------- --------------------------------------
Iehab J. Hawatmeh, President
5